✦ LIBER ✦

HEREDOPATHIA ATACTICA POLYNEURITIFORMIS (REFSUM'S DISEASE) TREATED BY DIET AND PLASMA-EXCHANGE

✍ Scribed by Gibberd, F.B.; Page, N.G.R.; Billimoria, J.D.; Retsas, S.

Book ID: 122920337
Publisher: The Lancet
Year: 1979
Tongue: English
Weight: 594 KB
Volume: 313
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(79)91005-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heredopathia atactica polyneuritiformis

Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma exchange—follow-up study of one case over eight years

✍ Kamanabroo, D.; Feldmann, H.; Schriever, H.; Van de Loo, J. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 381 KB

Heredopathia Atactica Polyneuritiformis.

Heredopathia Atactica Polyneuritiformis. (Phytanic acid storage disease. Refsum's disease). Effect of dietary treatment on retinal and cochlear changes.

✍ Sigvald Refsum 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Refsum's disease (heredopathia atactica

Refsum's disease (heredopathia atactica polyneuritiformis): An inborn error of lipid metabolism with storage of 3,7,11,15-tetramethyl hexadecanoic acid: II. Isolation and identification of the storage product

✍ W. Kahlke; R. Richterich 📂 Article 📅 1965 🏛 Elsevier Science 🌐 English ⚖ 505 KB

A Child with Refsum's Disease: Successfu

A Child with Refsum's Disease: Successful Treatment with Diet and Plasma Exchange

✍ Nigel Dickson; J. G. Mortimer; J. M. Faed; A. C. Pollard; M. Styles; D. A. Peart 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB

Drug-resistant bullous pemphigoid and in

Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy

✍ Gino Tripodi; Marco Risso; Loredana Tenerini; Paolo Gandullia; Emanuela Castella 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

## Abstract Bullous pemphigoid (BP) is an autoimmune skin disease that occurs mainly in elderly patients; onset of BP is rare in childhood. Inflammatory bowel diseases (IBD), by contrast, have a pediatric onset in 25% of presenting cases, requiring expert multidisciplinary management. Here we repor